Evidence map›Paper›PMID 32327445›Full record

ArticleBMJ open diabetes research & care2020

Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics.

Eu Jeong Ku, Kyung-Cho Cho, Cheong Lim, Jeong Won Kang, Jae Won Oh, Yu Ri Choi, Jong-Moon Park, Na-Young Han, Jong Jin Oh, Tae Jung Oh and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Proteomics techniques in protein biomarker discovery.Quantitative biology (Beijing, China) · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Proteomic Studies of Blood and Vascular Wall in Atherosclerosis.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Eu Jeong Ku *Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea.ORCID 0000-0001-5533-4989
Kyung-Cho Cho *Applied Chemisty, Kyung Hee University College of Applied Sciences, Yongin, South Korea.
Cheong LimThoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seongnam, South Korea.
Jeong Won KangApplied Chemisty, Kyung Hee University College of Applied Sciences, Yongin, South Korea.
Jae Won OhApplied Chemisty, Kyung Hee University College of Applied Sciences, Yongin, South Korea.
Yu Ri ChoiApplied Chemisty, Kyung Hee University College of Applied Sciences, Yongin, South Korea.
Jong-Moon ParkPharmaceutics, Gachon University College of Pharmacy, Incheon, South Korea.
Na-Young HanPharmaceutics, Gachon University College of Pharmacy, Incheon, South Korea.
Jong Jin OhUrology, Seoul National University Bundang Hospital, Seongnam, South Korea.
Tae Jung OhInternal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Hak Chul JangInternal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.ORCID 0000-0002-4188-6536
Hookeun LeePharmaceutics, Gachon University College of Pharmacy, Incheon, South Korea.
Kwang Pyo KimApplied Chemisty, Kyung Hee University College of Applied Sciences, Yongin, South Korea shchoimd@gmail.com kimkp@khu.ac.kr.
Sung Hee ChoiInternal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea shchoimd@gmail.com kimkp@khu.ac.kr.ORCID 0000-0003-0740-8116
Seoul National University · KRKyung Hee University · KRGachon University · KRChungbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiovascular disease (CVD) in patients with diabetes is the leading cause of death. Finding early biomarkers for detecting asymptomatic patients with CVD can improve survival. Recently, plasma proteomics-targeted selected reaction monitoring/multiple reaction monitoring analyses (MRM)-has emerged as highly specific and sensitive tools compared with classic ELISA methods. The objective was to identify differentially regulated proteins according to the severity of the coronary artery atherosclerosis. RESEARCH DESIGN AND

methodsA discovery cohort, a verification cohort and a validation cohort consisted of 18, 53, and 228 subjects, respectively. The grade of coronary artery stenosis was defined as a percentage of luminal stenosis of the major coronary arteries. Participants were divided into six groups, depending on the presence of diabetes and the grade of coronary artery stenosis. Two mass spectrometric approaches were employed: (1) conventional shotgun liquid chromatography tandem mass spectrometry for a discovery and (2) quantitative MRM for verification and validation. An analysis of the covariance was used to examine the biomarkers' predictivity beyond conventional cardiovascular risks.

resultsA total of 1349 different proteins were identified from a discovery cohort. We selected 52 proteins based on the tandem mass tag quantitative analysis then summarized as follows: chemokine (C-X-C motif) ligand 7 (CXCL7), apolipoprotein C-II (APOC2), human lipopolysaccharide-binding protein (LBP) and dedicator of cytokinesis 2 (DOCK2) in diabetes; CXCL7, APOC2, LBP, complement 4A (C4A), vitamin D-binding protein (VTDB) and laminin β1 subunit in non-diabetes. Analysis of covariance showed that APOC2, DOCK2, CXCL7 and VTDB were upregulated and C4A was downregulated in patients with diabetes showing severe coronary artery stenosis. LBP and VTDB were downregulated in patients without diabetes, showing severe coronary artery stenosis.

conclusionWe identified significant associations between circulating APOC2, C4A, CXCL7, DOCK2, LBP and VTDB levels and the degree of coronary artery stenosis using the MRM technique.

Indexed as

AtherosclerosisCoronary Artery DiseaseBiomarkersHumansProteomicsBiomarkersbiomarkerscoronary artery diseaseproteomic analysistype 2 diabetes

Identifiers

PMID32327445
PMCPMC7202779
OpenAlexW3020397893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.